A Troubling Glitch in the System: Novo Nordisk's Data Breach Exposes Patient Secrets
Edgewise Therapeutics Unveils Exciting Cardiac Trial Data for Becker Muscular Dystrophy Drug
Biotech's Reawakening: A Cautious Comeback for IPOs
The Biotech Tango: Why Merck Pumped the Brakes on Terns Pharmaceuticals' Acquisition
A New Horizon in Glaucoma Care: Bausch + Lomb's ELIOS System Shines in Pivotal Trial
Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena
Guardant Health Shares Plummet as Landmark Cancer Test Trial Fails to Meet Primary Endpoint